PA
ABBV icon

Procyon Advisors’s AbbVie ABBV Stock Holding History

Procyon Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.15M Sell
32,392
-447
-1% -$96.2K 0.35% 63
2026
Q1 		$7.14M Buy
32,839
+87
+0.3% +$19.3K 0.35% 67
2025
Q4 		$7.48M Buy
32,752
+5,427
+20% +$1.24M 0.37% 65
2025
Q3 		$6.33M Buy
27,325
+1,933
+8% +$394K 0.37% 62
2025
Q2 		$4.71M Sell
25,392
-6,771
-21% -$1.26M 0.44% 53
2025
Q1 		$6.74M Buy
32,163
+4,302
+15% +$836K 0.41% 57
2024
Q4 		$4.95M Buy
27,861
+214
+0.8% +$39.3K 0.31% 72
2024
Q3 		$5.46M Sell
27,647
-1,227
-4% -$229K 0.37% 60
2024
Q2 		$4.95M Buy
28,874
+798
+3% +$132K 0.37% 60
2024
Q1 		$5.11M Sell
28,076
-2,112
-7% -$364K 0.4% 61
2023
Q4 		$4.68M Sell
30,188
-924
-3% -$135K 0.4% 56
2023
Q3 		$4.64M Buy
31,112
+2,811
+10% +$413K 0.48% 49
2023
Q2 		$3.81M Sell
28,301
-1,495
-5% -$219K 0.48% 48
2023
Q1 		$4.75M Buy
29,796
+563
+2% +$86.1K 0.79% 29
2022
Q4 		$4.72M Buy
29,233
+4,287
+17% +$657K 0.87% 25
2022
Q3 		$3.35M Sell
24,946
-3,210
-11% -$461K 0.82% 24
2022
Q2 		$4.31M Sell
28,156
-5,675
-17% -$867K 0.95% 22
2022
Q1 		$5.48M Buy
33,831
+1,898
+6% +$276K 1.13% 16
2021
Q4 		$4.32M Buy
31,933
+2,280
+8% +$269K 0.92% 21
2021
Q3 		$3.2M Buy
29,653
+1,920
+7% +$219K 0.82% 28
2021
Q2 		$3.12M Buy
27,733
+8,617
+45% +$970K 0.85% 29
2021
Q1 		$2.07M Buy
19,116
+238
+1% +$25.5K 0.92% 25
2020
Q4 		$2.02M Buy
18,878
+1,066
+6% +$102K 0.99% 23
2020
Q3 		$1.56M Buy
17,812
+12
+0.1% +$1.13K 0.87% 29
2020
Q2 		$1.75M Buy
17,800
+962
+6% +$84.7K 0.93% 25
2020
Q1 		$1.28M Buy
16,838
+2,753
+20% +$234K 0.85% 29
2019
Q4 		$1.25M Buy
+14,085
New +$1.17M 0.76% 33

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Procyon Advisors's ABBV Position: Q2 2026 in Review

Procyon Advisors reduced its AbbVie (ABBV) stake by 1.4% in Q2 2026, selling an estimated $96.2K and leaving 32,392 shares worth $8.15M. The position accounts for 0.35% of the portfolio, ranked #63.

Procyon Advisors first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Procyon Advisors held 32,392 shares of AbbVie worth $8.15M as of Q2 2026.
  • Procyon Advisors sold 447 AbbVie shares in Q2 2026, an estimated $96.2K.
  • AbbVie made up 0.35% of Procyon Advisors's portfolio in Q2 2026, its #63 holding.
  • Procyon Advisors first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.